Potential Immune-Related Adverse Events Associated With Monotherapy and Combination Therapy of Ipilimumab, Nivolumab, and Pembrolizumab for Advanced Melanoma: A Systematic Review and Meta-Analysis

Abdulaali R. Almutairi, Ali McBride, Marion Slack, Brian L. Erstad, Ivo Abraham

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations

Fingerprint Dive into the research topics of 'Potential Immune-Related Adverse Events Associated With Monotherapy and Combination Therapy of Ipilimumab, Nivolumab, and Pembrolizumab for Advanced Melanoma: A Systematic Review and Meta-Analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences